Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. (Q43299563)
Jump to navigation
Jump to search
scientific article published in October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. |
scientific article published in October 2009 |
Statements
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study (English)
Richard E Pratley
Penny R Fleck
Craig A Wilson
Qais Mekki
Alogliptin Study 009 Group
1 October 2009